Immatics (IMTX) Cash from Discontinued Operations (2019 - 2024)
Immatics (IMTX) reported Cash from Discontinued Operations of 37041845.6 for Q3 2024, down 11.47% on a YoY basis from 41841031.88 in Q4 2023, and down 11.47% sequentially from 33230312.89 in Q3 2023.
Immatics (IMTX) Cash from Discontinued Operations (2019 - 2024) Analysis & Trends
Immatics (IMTX) has 6 years of Cash from Discontinued Operations data on file, last reported at 37041845.6 in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Discontinued Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Immatics | 1.06 Bn | 515.66 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | -37.04 Mn |
| Sep 30, 2024 | -37.04 Mn |
| Sep 30, 2023 | -33.23 Mn |
| Sep 30, 2023 | -33.23 Mn |
| Mar 31, 2022 | 122.45 Bn |
| Mar 31, 2022 | 122.45 Bn |
| Mar 31, 2021 | 20.09 Bn |
| Mar 31, 2021 | 20.09 Bn |
| Sep 30, 2020 | 83.61 Bn |
| Sep 30, 2020 | 83.61 Bn |
| Jun 30, 2020 | -292.99 Mn |
| Jun 30, 2020 | -292.99 Mn |
| Mar 31, 2020 | -12.64 Bn |
| Mar 31, 2020 | -12.64 Bn |
| Sep 30, 2019 | 52.66 Bn |
| Sep 30, 2019 | 52.66 Bn |